By Ionswelcure Drugs
AgenciesRepresentative image
Welcure Drugs & Pharmaceuticals on Tuesday said it has bagged two export orders worth Rs 85.6 crore from Giant Exim and Ravina International. On June 30, the company received a Rs 42.8 crore order each from Giant Exim and Ravina International for procurement and consolidation of mycorrhizal inoculant (EXW), a statement said. “The orders will contribute fee-based revenue, with no inventory or logistics risk to the company,” it added. The company is in advanced discussions with additional international buyers for similar export sourcing mandates and expects to conclude further orders worth Rs 20 crore or more within the ongoing quarter, Welcure said. It recently secured a Rs 517 crore global sourcing mandate from Thailand-based Fortune Sagar Impex Company.Live Events “The company remains focused on expanding its fee-based export portfolio while maintaining its debt-free capital structure,” Welcure stated.(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onWelcure Drugs & PharmaGiant EximRavina Internationalinternational buyersWelcure Drugs & PharmaceuticalsFortune Sagar Impex Companyglobal sourcing mandate
(Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online….moreless
(You can now subscribe to our Economic Times WhatsApp channel)Read More News onWelcure Drugs & PharmaGiant EximRavina Internationalinternational buyersWelcure Drugs & PharmaceuticalsFortune Sagar Impex Companyglobal sourcing mandate(Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online….moreless